Hengoed

Hengoed became a named destination for UK life-sciences capital on 14 April 2026, when Norgine, a European specialty pharmaceutical company, received over £20m from the Life Sciences Innovative Manufacturing Fund (LSIMF) for its manufacturing site in the village. The award is one of four in the 2026 LSIMF round, all deliberately located outside the Oxford-Cambridge-London triangle, and represents the largest single life-sciences manufacturing investment in South Wales in recent years.

Hengoed is a village in the Caerphilly county borough of South Wales, in the Rhymney Valley approximately 12 miles north of Cardiff. The surrounding area was historically a coal-mining district and has faced persistent economic challenges since the colliery closures of the 1980s. Caerphilly county borough now hosts a diversified industrial base including logistics, light manufacturing, and public-sector employment, with Norgine's site representing one of its more significant private-sector anchors.

Norgine's presence in Hengoed, and the LSIMF's willingness to back it with over £20m, signals that the UK Government views South Wales as a viable location for specialist pharmaceutical manufacturing rather than merely a recipient of lower-value industrial subsidy. For communities in the former coalfield, the investment carries significance beyond its headline figure: it demonstrates that deep-tech manufacturing investment can reach valleys communities, not just the M4 corridor cities.